T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$742M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$647M |
| 4 |
Flowserve
FLS
|
+$577M |
| 5 |
Visa
V
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$909M |
| 2 |
Union Pacific
UNP
|
+$741M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$580M |
| 4 |
Edwards Lifesciences
EW
|
+$531M |
| 5 |
Accenture
ACN
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.66% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 11.61% |
| 5 | Technology | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
STRATTEC Security
STRT
$341M
| $20M | 0.01% |
521,500
-1,000
| -0.2% | -$38.8K |
|
1077
Apogee Enterprises
APOG
$897M
| $19.9M | 0.01% |
+671,600
| New | +$18.5M |
|
|
PTLA
1078
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $19.7M | ﹤0.01% |
745,779
-32,000
| -4% | -$761K |
|
1079
Pentair
PNR
$10.5B
| $19.7M | ﹤0.01% |
450,670
-12,805
| -3% | -$534K |
|
|
SHLO
1080
DELISTED
Shiloh Industries Inc
SHLO
| $19.6M | ﹤0.01% |
1,498,890
| – | – |
|
1081
KLA
KLAC
$274B
| $19.5M | ﹤0.01% |
3,206,050
+120,000
| +4% | +$704K |
|
|
PNNT
1082
Pennant Park Investment Corp
PNNT
$249M
| $19.4M | ﹤0.01% |
1,724,300
-300
| -0% | -$3.42K |
|
|
HBI
1083
DELISTED
Hanesbrands
HBI
| $19.3M | ﹤0.01% |
1,240,800
+208,000
| +20% | +$3.09M |
|
1084
LivePerson
LPSN
$35.9M
| $19.3M | ﹤0.01% |
136,335
+43,955
| +48% | +$6.42M |
|
|
CVT
1085
DELISTED
CVENT, INC.
CVT
| $19.2M | ﹤0.01% |
+546,500
| New | +$19.9M |
|
1086
Cohu
COHU
$2.76B
| $19.2M | ﹤0.01% |
1,758,040
+79,300
| +5% | +$906K |
|
1087
Preferred Bank
PFBC
$1.26B
| $19.2M | ﹤0.01% |
1,077,721
+42,264
| +4% | +$715K |
|
1088
Insulet
PODD
$10.1B
| $19.2M | ﹤0.01% |
528,746
-259,954
| -33% | -$8.72M |
|
1089
Itaú Unibanco
ITUB
$80.9B
| $19.1M | ﹤0.01% |
3,702,617
-2,658,240
| -42% | -$12.5M |
|
1090
Weyco Group
WEYS
$446M
| $19.1M | ﹤0.01% |
672,670
-300
| -0% | -$8.03K |
|
1091
Eversource Energy
ES
$27.2B
| $19M | ﹤0.01% |
460,504
+200
| +0% | +$8.46K |
|
|
ESV
1092
DELISTED
Ensco Rowan plc
ESV
| $18.9M | ﹤0.01% |
87,823
-218,708
| -71% | -$50.1M |
|
1093
Conagra Brands
CAG
$7.39B
| $18.8M | ﹤0.01% |
795,379
-16,564
| -2% | -$447K |
|
1094
Clearway Energy Class C
CWEN
$7.06B
| $18.7M | ﹤0.01% |
+1,236,220
| New | +$17.7M |
|
|
CALD
1095
DELISTED
Callidus Software, Inc.
CALD
| $18.7M | ﹤0.01% |
2,035,470
-20,500
| -1% | -$155K |
|
1096
Community Health Systems
CYH
$410M
| $18.6M | ﹤0.01% |
542,893
+4,598
| +0.9% | +$163K |
|
1097
Clarus
CLAR
$141M
| $18.6M | ﹤0.01% |
1,537,353
-1,005
| -0.1% | -$10.7K |
|
1098
Berkshire Hathaway Class A
BRK.A
$1.09T
| $18.6M | ﹤0.01% |
109
| – | – |
|
|
KEG
1099
DELISTED
KEY ENERGY SERVICES INC
KEG
| $18.5M | ﹤0.01% |
2,538,580
-9,520
| -0.4% | -$69.4K |
|
1100
Skywest
SKYW
$4.16B
| $18.5M | ﹤0.01% |
1,274,250
+171,260
| +16% | +$2.46M |
|
Similar funds
T. Rowe Price Associates's Q3 2013 Portfolio in Review
As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
- T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
- T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
- T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
- T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
- T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.
Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.